Hypertriglyceridemia
207
14
22
145
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
45 trials with published results (22%)
Research Maturity
145 completed trials (70% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.8%
14 terminated out of 207 trials
91.2%
+4.7% vs benchmark
30%
62 trials in Phase 3/4
31%
45 of 145 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 145 completed trials
Clinical Trials (207)
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia
WB-EMS Effects on Cardiometabolic Risk Factors
Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Russian Extreme Hypertriglyceridemia Registry
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Single-ascending Dose Study of Kylo-12 in Healthy Subjects
A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
A Study of SHR-1918 In Participants With Hypertriglyceridemia
MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia
Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia
Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients
Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)
Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment
Study of MAR001 in Adults With Metabolic Dysfunction